Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:01 AM
Ignite Modification Date:
2025-12-25 @ 2:01 AM
NCT ID:
NCT00750360
Eligibility Criteria:
Inclusion Criteria:
* A male or female \> 6 months of age at the time of the first vaccination.
* Subjects who the investigator believes that they and/or their parents/guardians can and will comply with the requirements of the protocol should be enrolled in the study.
* Free of obvious health problems as established by medical history and clinical examination judged by the investigator before entering into the study.
* If the subject is female, she must be of non-childbearing potential, or, if of childbearing potential, she must be abstinent or have used adequate contraceptive precautions for 30 days prior to vaccination, have a negative pregnancy test and must agree to continue such precautions for two months after vaccination.
Exclusion Criteria:
* Clinical signs of acute febrile illness at the time of entry into the study.
* Any treatment with immunosuppressive drugs, including oral and parenteral corticosteroids.
* History of allergic disease or reactions likely to be exacerbated by any component of the vaccine or previous severe reaction to influenza virus vaccine.
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
6 Months
Study:
NCT00750360
Study Brief:
Protocol Section:
NCT00750360